You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Natalizumab (Tysabri)-Associated Progressive Multifocal Leukoencephalopathy: Insights From Perfusion Magnetic Resonance Imaging

Elster, Martha J. BA

Journal of Computer Assisted Tomography:
doi: 10.1097/RCT.0b013e318298aa0d
Neuroradiology
Abstract

Abstract: A case of natalizumab-associated progressive multifocal leukoencephalopathy in a 38-year-old woman is presented showing characteristics on magnetic resonance imaging (MRI) with high signal on T2-weighted images and patchy contrast enhancement. After 5 days of plasma exchange therapy, contrast enhancement decreased, but the abnormality on T2-weighted images increased. Perfusion MRI at this time demonstrated significantly increased blood flow to the lesion. Thirteen days after initiation of treatment, perfusion MR returned to normal in advance of significant anatomical changes on conventional MRIs. This case suggests that MR perfusion imaging may be helpful in monitoring the treatment of patients with natalizumab-associated progressive multifocal leukoencephalopathy.

Author Information

From the Department of Radiology, Wake Forest School of Medicine, Wake Forest University, Winston-Salem, NC.

Received for publication April 21, 2013; accepted April 23, 2013.

The author has no conflict of interest to declare.

Reprints: Martha J. Elster, BA, Department of Radiology, Wake Forest School of Medicine, Medical Center Blvd, Winston-Salem, NC 27157 (e-mail: melster@wakehealth.edu).

© 2013 by Lippincott Williams & Wilkins